Clinical Trial Update: Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating platinum- cetuximab with docetaxel or with 5-FU in recurrent/metastatic head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)
• Platinum (Platinum-based chemotherapy)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED